Detection of vimentin (VIM) methylation in the serum of colorectal cancer patients

Anticancer Research

Volumn 30, Issue 12, 2010, Pages 5015-5018

  Shirahata, Atsushi ^a   Sakuraba, Kazuma ^a   Goto, Tetsuhiro ^a   Saito, Mitsuo ^a   Ishibashi, Kazuyoshi ^a   Kigawa, Gaku ^a   Nemoto, Hiroshi ^a   Hibi, Kenji ^a  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

Colorectal carcinoma; Quantitative methylation specific PCR; VIM

Indexed keywords

VIMENTIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; DNA DETERMINATION; FEMALE; HUMAN; LIVER METASTASIS; MALE; METHYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

AGED; COLORECTAL NEOPLASMS; DNA METHYLATION; DNA, NEOPLASM; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; VIMENTIN;

EID: 78751555131     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Leon SA, Shapiro B, Sklaroff DM and Yaros MJ: Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37: 646-650, 1977. (Pubitemid 8051621)
2. Stroun M, Anker P, Maurice P, Lyautey J, Lederrey C and Beljanski M: Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology 46: 318-322, 1989. (Pubitemid 19216753)
3. Hibi K, Robinson CR, Booker S, Wu L, Hamilton SR, Sidransky D and Jen J: Molecular detection of genetic alterations in the serum of colorectal cancer patients. Cancer Res 55: 1405-1407, 1998. (Pubitemid 28193600)
4. Mulcahy HE, Lyautey J, Lederrey C, Qi Chen X, Anker P, Alstead EM, Ballinger A, Farthing MJ and Stroun M: A prospective study of K-ras mutations in the plasma of pancreatic cancer patients. Clin Cancer Res 4: 271-275, 1998.
5. Ito S, Hibi K, Nakayama H, Kodera Y, Ito K, Akiyama S and Nakao A: Detection of tumor DNA in serum of colorectal cancer patients. Jpn J Cancer Res 93: 1266-1269, 2002.
6. Uemura T, Hibi K, Kaneko T, Takeda S, Inoue S, Okochi O, Nagasaka T and Nakao A: Detection of oncogenic mutation in the plasma DNA of pancreatic cancer patients. J Gastroenterol 39: 56-60, 2004.
7. Hibi K, Nakayama H, Yamazaki T, Takase T, Taguchi M, Kasai Y, Ito K, Akiyama S and Nakao S: Detection of mitochondrial DNA alterations in primary tumors and corresponding serum of colorectal cancer patients. Int J Cancer 94: 429-431, 2001.
8. Okochi O, Hibi K, Uemura T, Inoue S, Takeda S, Kaneko T and Nakao A: Detection of mitochondrial DNA alterations in the serum of hepatocellular carcinoma patients. Clin Cancer Res S: 2875-2878, 2002.
9. ink4A alleles in neoplasia. Cancer Res 55: 591-593, 1998.
10. Esteller M, Tortola S, Toyota M, Capella G, Peinado MA, Baylin SB and Herman JG: Hypermethylation-associated inactivation of p14 (ARF) is independent of p16 (INK4a) methylation and p53 mutational status. Cancer Res 60: 129-133, 2000.
11. Hibi K, Nakayama H, Kanyama Y, Kodera Y, Ito K, Akiyama S and Nakao A: Methylation pattern of HLTF gene in digestive tract cancers. Int J Cancer 104: 433-436, 2003.
12. Fujitake S, Hibi K, Okochi O, Kodera Y, Ito K, Akiyama S and Nakao A: Aberrant methylation of SOCS-1 was observed in younger colorectal cancer patients. J Gastroenterol 39: 120-124, 2004.
13. Hibi K, Nakayama H, Kodera Y, Ito K, Akiyama S and Nakao A: CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer. Br J Cancer 90: 1030-1033,2004. (Pubitemid 38495824)
14. Nakayama H, Hibi K, Taguchi M, Takase T, Yamazaki T, Kasai Y, Ito K, Akiyama S and Nakao A: Molecular detection of p/6 promoter methylation in the serum of colorectal cancer patients. Cancer lett 188: 115-119, 2002. (Pubitemid 35292337)
15. Itzkowitz SH, Jandorf L, Brand R, Rabeneck L, Schroy PCIII, Sontag S, Johnson D, Skoletsky J, Durkee K, Markowitz S and Shuber A: Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol 5: 111-117, 2007. (Pubitemid 46096834)
16. Zou H, Harrington JJ, Shire AM, Rego RL, Wang L, Campbell ME, Oberg AL and Ahlquist DA: Highly methylated genes in colorectal neoplasia: implications for screening. Cancer Epidemiol Biomarkers Prev 16: 2685-2696, 2007. (Pubitemid 351196325)
17. Brenner DE and Rennen G: Fecal DNA biomarkers for the detection of colorectal neoplasia: Attractive, but is it feasible? J Natl Cancer Inst 97: 1107-1109, 2005.
18. Zou H, Harrington J, Rego RL and Ahlquist DA: A novel method to capture methylated human DNA from stool: Implications for colorectal cancer screening. Clin Chem 53: 1646-1651, 2007. (Pubitemid 47340061)
19. Hibi K, Nakamura H, Hirai A, Fujikake Y, Kasai Y, Akiyama S, Ito K and Takagi H: Loss of H19 imprinting in esophageal cancer. Cancer Res 56: 480-482, 1996. (Pubitemid 26048601)
20. Hibi K, Taguchi M, Nakayama H, Takase T, Kasai Y, Ito K, Akiyama S and Nakao A: Molecular detection of p 16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma. Clin Cancer Res 7: 3135-3138, 2001.
21. Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB and Herman JG: Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 59: 67-70, 1999. (Pubitemid 29062958)
22. Wong IH, Lo YM, Zhang J, Liew CT, Ng MH, Wong N, Lai PB, Lau WY, Hjelm NM and Johnson PJ: Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res 59: 71-73, 1999.
23. Nakayama H, Hibi K, Takase T, Yamazaki T, Kasai Y, Ito K, Akiyama S and Nakao A: Molecular detection of p16 promoter methylation in the serum of recurrent colorectal cancer patients. Int J Cancer 105: 491-493, 2003.
24. Sanchez-Cespedes M, Esteller M, Wu L, Nawroz-Danish H, Yoo GH, Koch WM, Jen J, Herman JG and Sidransky D: Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res 60: 892-895, 2000. (Pubitemid 30129522)
25. Vogelstein B and Kinzler KW: Digital PCR. Proc Natl Acad Sci USA 96: 9236-9241, 1999.